Patent 7807780 was granted and assigned to Revance Therapeutics, Inc. on October, 2010 by the United States Patent and Trademark Office.
Compositions and methods are provided that are useful for the delivery of therapeutic agents, including nucleic acids. The compositions can be prepared with components useful for targeting the delivery of the compositions as well as imaging components.